/Companies

Pionarus Bio, Inc.

1 known investors

Find your way into Pionarus Bio, Inc.

Sign up to see every warm intro you have to Pionarus Bio, Inc.

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Pionarus Bio, Inc. team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Pionarus develops synthetically produced, precision-designed cannabinoid compounds targeting women's health conditions such as menopause and metabolic disease. The company focuses on pharmaceutical-grade cannabinoid therapies optimized for target selectivity, oral bioavailability, and regulatory clarity.

Investors · 1

Frequently asked questions

What does Pionarus Bio, Inc. do?
Pionarus develops synthetically produced, precision-designed cannabinoid compounds targeting women's health conditions such as menopause and metabolic disease. The company focuses on pharmaceutical-grade cannabinoid therapies optimized for target selectivity, oral bioavailability, and regulatory clarity.
Who are Pionarus Bio, Inc.'s investors?
Pionarus Bio, Inc.'s investors include Colorado BioScience Association.